These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2692018)

  • 1. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats.
    Deurloo MJ; Hermens WA; Romeyn SG; Verhoef JC; Merkus FW
    Pharm Res; 1989 Oct; 6(10):853-6. PubMed ID: 2692018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats.
    van Hoogdalem EJ; Heijligers-Feijen CD; Verhoef JC; de Boer AG; Breimer DD
    Pharm Res; 1990 Feb; 7(2):180-3. PubMed ID: 2106676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep.
    Longenecker JP; Moses AC; Flier JS; Silver RD; Carey MC; Dubovi EJ
    J Pharm Sci; 1987 May; 76(5):351-5. PubMed ID: 3309255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.
    Kissel T; Drewe J; Bantle S; Rummelt A; Beglinger C
    Pharm Res; 1992 Jan; 9(1):52-7. PubMed ID: 1589410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.
    Lee WA; Narog BA; Patapoff TW; Wang YJ
    J Pharm Sci; 1991 Aug; 80(8):725-9. PubMed ID: 1791529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique.
    Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y
    Biol Pharm Bull; 1999 Oct; 22(10):1089-93. PubMed ID: 10549861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models.
    Baldwin PA; Klingbeil CK; Grimm CJ; Longenecker JP
    Pharm Res; 1990 May; 7(5):547-52. PubMed ID: 2367323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
    van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro.
    Hermens WA; Hooymans PM; Verhoef JC; Merkus FW
    Pharm Res; 1990 Feb; 7(2):144-6. PubMed ID: 2408030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
    Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y
    Arch Pharm Res; 1994 Apr; 17(2):57-9. PubMed ID: 10319131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats.
    Raehs SC; Sandow J; Wirth K; Merkle HP
    Pharm Res; 1988 Nov; 5(11):689-93. PubMed ID: 3150047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
    Schipper NG; Romeijn SG; Verhoef JC; Merkus FW
    Pharm Res; 1993 May; 10(5):682-6. PubMed ID: 8321831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.
    Merkus FW; Verhoef JC; Romeijn SG; Schipper NG
    Pharm Res; 1991 May; 8(5):588-92. PubMed ID: 1866372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
    Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
    Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits.
    Najafabadi AR; Moslemi P; Tajerzadeh H
    Drug Deliv; 2004; 11(5):295-300. PubMed ID: 15742554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
    Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD
    J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal absorption of insulin in the rat: effect of penetration enhancers on insulin uptake and mucosal histology.
    Richardson JL; Illum L; Thomas NW
    Pharm Res; 1992 Jul; 9(7):878-83. PubMed ID: 1438000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
    Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
    Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal delivery of insulin using bioadhesive chitosan gels.
    Varshosaz J; Sadrai H; Heidari A
    Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
    Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
    J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.